{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF00071",
      "entity_text" : "RAS",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BYF1",
      "entity_text" : "ACE2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR Preclinical studies have shown that after binding of SARS-CoV to its receptor, ACE2 activates RAS leading to downregulation of the expression of ACE2, which in turn results in excessive production of Ang II. XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR Therefore, ACE2 plays a dual role in COVID-19 : Initially, it acts as a receptor for SARS-CoV-2 entry, then, in the context of SARS-CoV-2 infection, ACE2 is downregulated, which increases Ang II.",
  "reading_complete" : "2020-08-02T13:07:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:05:44Z",
  "trigger" : "activates",
  "evidence" : [ "ACE2 activates RAS" ],
  "pmc_id" : "7319800",
  "score" : 0
}